CN104119269A - Synthetic method of 6-isopropyl nicotinic acid - Google Patents

Synthetic method of 6-isopropyl nicotinic acid Download PDF

Info

Publication number
CN104119269A
CN104119269A CN201310146525.1A CN201310146525A CN104119269A CN 104119269 A CN104119269 A CN 104119269A CN 201310146525 A CN201310146525 A CN 201310146525A CN 104119269 A CN104119269 A CN 104119269A
Authority
CN
China
Prior art keywords
nicotinic acid
acid
limited
sec
synthetic method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310146525.1A
Other languages
Chinese (zh)
Inventor
黄传满
邵东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KEJIE-BIO (SUZHOU) PHARMACEUTICAL Co Ltd
Original Assignee
KEJIE-BIO (SUZHOU) PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KEJIE-BIO (SUZHOU) PHARMACEUTICAL Co Ltd filed Critical KEJIE-BIO (SUZHOU) PHARMACEUTICAL Co Ltd
Priority to CN201310146525.1A priority Critical patent/CN104119269A/en
Publication of CN104119269A publication Critical patent/CN104119269A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Abstract

The invention discloses a novel synthetic method of 6-isopropyl nicotinic acid. Nicotinic acid as a starting material is subjected to a one-step Minisci reaction to obtain the 6-isopropyl nicotinic acid. The method has the advanategs of mild and simple reaction conditions, low cost, high yield and simple operation, and is suitable for large-scale industrial production.

Description

A kind of synthetic method of 6-sec.-propyl nicotinic acid
Technical field
The present invention relates to a kind of new synthesis process of 6-sec.-propyl nicotinic acid, belong to medicine, chemical technology field.
Background technology
Nicotinic acid is also referred to as vitamin B3, or vitamin PP, is one of 13 kinds of VITAMIN of needed by human, is a kind of water-soluble vitamins, belongs to vitamin B complex.Nicotinic acid, for antipellagra, also can be used as blood expansion medicine, is used as in a large number the additive of food and feed; As medicine intermediate, can stop and the production of Vasonicit etc. for vazadrine, niacinamide, Buddhist nun.Its derivative is also widely used in biomedicine field, has good antiallergic activity (JMC1989,32 (3), 583-593; EP1852431).
The synthetic method of bibliographical information has as follows:
Route A (JACS1951,73,1368; WO2007/76034; WO2008/133753; JMC1989,32 (3), 583-593; EP1852431; BMCL2012,22 (6), 2212-2215; Zeitschrift fuer Naturforschung, B:Chemical Sciences, 2004,59 (10), 1121-1131).
Route B (US6350764)
Route C (WO2012/171337)
Route D (EJMC198924,517-530; JOC1999,64 (26), 9493-9498)
In route A, C, D, reaction yield is lower, reaction product complexity, and step is long.
In route B, raw material is not easy to obtain, and product purification difficulty is larger.
Comprehensively more above-mentioned four routes, reaction yield is lower, reaction product complexity, and step is long, also has raw material to be not easy to obtain, and product purification difficulty is large.
Summary of the invention
The present invention seeks to select a new synthetic route to prepare 6-sec.-propyl nicotinic acid, the method raw material is easy to get, inexpensive, and productive rate is high, and reaction conditions gentleness is suitable for a large amount of preparations.
Reaction scheme is as follows:
The new synthesis process of 6-sec.-propyl nicotinic acid of the present invention, in synthetic 6-sec.-propyl nicotinic acid (compound 3): Minisci reacts oxygenant used, including but not limited to ammonium persulphate, hydrogen peroxide, peroxy tert-butyl alcohol etc.; Catalyzer used, including but not limited to Silver Nitrate, ferrous sulfate etc.; Radical precursor used, including but not limited to isopropylformic acid, isopropyl iodide etc.; Acid used, including but not limited to sulfuric acid etc.; Reaction solvent is water, can be also DMSO, DMF, acetone etc.; Temperature of reaction is at 70-90 DEG C.
The present invention compared with prior art has following beneficial effect:
1, raw material nicotinic acid is cheap and easy to get, and productive rate is higher, and the reaction times is short.
2, reactions steps is short, only has single step reaction, has avoided loaded down with trivial details operation, has greatly improved working efficiency.
3, whole reaction scheme mild condition, is suitable for a large amount of preparations.
Embodiment
Embodiment 1: synthetic 6-sec.-propyl nicotinic acid (compound 3)
In the mixing solutions of nicotinic acid (1g, 8.1 mmoles) water-soluble (10 milliliters) and the vitriol oil (0.5 milliliter), under nitrogen protection, add isopropylformic acid (1.4g, 16.2 mmoles).Lucifuge adds Silver Nitrate (140mg, 0.1 mmole), ammonium persulphate (3.7g, 16.2 mmoles), is heated to 90 DEG C, stirs 3 hours.Be chilled to 0 DEG C, be neutralized to pH10, ethyl acetate extraction.Merge organic interdependent time and wash with saturated sodium bicarbonate solution and salt, anhydrous sodium sulfate drying.Concentrating under reduced pressure, residue ether recrystallization, vacuum-drying obtains compound (3) 0.88g, productive rate: 65.7%.

Claims (2)

1. the present invention discloses a kind of novel synthesis of 6-sec.-propyl nicotinic acid, Minisci occurs taking nicotinic acid as starting raw material and react a step and obtain target compound 6-sec.-propyl nicotinic acid.
2. the synthetic method of 6-sec.-propyl nicotinic acid as claimed in claim, is characterized in that: Minisci reacts oxygenant used, including but not limited to ammonium persulphate, hydrogen peroxide, peroxy tert-butyl alcohol etc.; Catalyzer used, including but not limited to Silver Nitrate, ferrous sulfate etc.; Radical precursor used, including but not limited to isopropylformic acid, isopropyl iodide etc.; Acid used, including but not limited to sulfuric acid etc.; Reaction solvent is water, can be also DMSO, DMF, acetone etc.; Temperature of reaction is at 70-90 DEG C.
CN201310146525.1A 2013-04-25 2013-04-25 Synthetic method of 6-isopropyl nicotinic acid Pending CN104119269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310146525.1A CN104119269A (en) 2013-04-25 2013-04-25 Synthetic method of 6-isopropyl nicotinic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310146525.1A CN104119269A (en) 2013-04-25 2013-04-25 Synthetic method of 6-isopropyl nicotinic acid

Publications (1)

Publication Number Publication Date
CN104119269A true CN104119269A (en) 2014-10-29

Family

ID=51764935

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310146525.1A Pending CN104119269A (en) 2013-04-25 2013-04-25 Synthetic method of 6-isopropyl nicotinic acid

Country Status (1)

Country Link
CN (1) CN104119269A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108658853A (en) * 2018-05-03 2018-10-16 苏州大学 A kind of 4- azepines aryl-triacontanol compound and its synthetic method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053121A2 (en) * 2004-11-10 2006-05-18 Cgi Pharmaceuticals, Inc. Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
WO2006138350A2 (en) * 2005-06-15 2006-12-28 Anormed Inc. Chemokine receptor binding compounds
CN101223141A (en) * 2005-03-10 2008-07-16 Cgi药品股份有限公司 Certain substituted amides, method of making, and method of use thereof
CN101309690A (en) * 2005-08-16 2008-11-19 阿诺麦德股份有限公司 Chemokine receptor binding compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006053121A2 (en) * 2004-11-10 2006-05-18 Cgi Pharmaceuticals, Inc. Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
US20060178367A1 (en) * 2004-11-10 2006-08-10 Currie Kevin S Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
CN101223141A (en) * 2005-03-10 2008-07-16 Cgi药品股份有限公司 Certain substituted amides, method of making, and method of use thereof
WO2006138350A2 (en) * 2005-06-15 2006-12-28 Anormed Inc. Chemokine receptor binding compounds
CN101309690A (en) * 2005-08-16 2008-11-19 阿诺麦德股份有限公司 Chemokine receptor binding compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108658853A (en) * 2018-05-03 2018-10-16 苏州大学 A kind of 4- azepines aryl-triacontanol compound and its synthetic method
CN108658853B (en) * 2018-05-03 2021-12-03 苏州大学 4-nitrogen heteroaryl alkanol compound and synthesis method thereof

Similar Documents

Publication Publication Date Title
CN102993246A (en) Method for synthesizing isopropyl-beta-D-thiogalactoside
CN105218621A (en) One class dehydroabietic acid Benzimidazole Schiff base class Hete rocyclic derivatives with anti-tumor activity and its preparation method and application
CN104119269A (en) Synthetic method of 6-isopropyl nicotinic acid
CN101734690A (en) Method for preparing potassium nitrate by solvent extraction method
CN105330560A (en) Enzalutamide intermediate preparation method
CN104530090A (en) Pyridine derivative preparing method
CN103626810A (en) Method for catalyzing glucose by using magnetic solid acid to produce methyl glucoside
CN103601759B (en) A kind of preparation method being used for the treatment of ruthenium (III) complex compound of tumour
CN105294474A (en) Method for preparing menthane diacetyl amide from p-menthadiene
CN105037073A (en) Synthetic method for biaryl compounds
CN104744537A (en) Synthetic method of capecitabine
CN102786551A (en) Preparation method of bis-triphenylphosphine palladium dichloride
CN101759205A (en) Method for preparing potassium nitrate by extracting n-butyl alcohol
CN112707860A (en) Synthesis method of active intermediate 4-chloro-3-nitropyridine
CN106349242A (en) Preparation method of 7-azaindole with position 3 substituted by halogen
CN103113254B (en) Technology for directly synthesizing acetaminophen from nitrobenzene
CN102101841A (en) Method for synthesis preparation of 2-chloro-4-aminopyridine
CN101985451A (en) Preparation method of prasugrel intermediate
CN102249990B (en) Process for synthesizing 6-(trifluoromethyl)pyridine-3-carboxaldehyde
CN103896834A (en) 2-Cyano-3-cyclobutylpyridine and chemical synthesis method thereof
CN104649874A (en) Method for preparing 3,3-dimethyl-1-butyraldehyde by 3,3-dimethyl-1-butanol through dehydrogenation
CN103554019A (en) Synthetic method of tilbroquinol
CN103044321A (en) Synthesis process of 2,6-diacetyl pyridine
CN102731613B (en) Preparation method of L-alanyl-L-glutamine
CN103191781A (en) Technology for preparing phenol by one-step catalytic oxidation of benzene through coordination of molecular sieve immobilized Schiff base and metal salt

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
DD01 Delivery of document by public notice

Addressee: Kejie-Bio (Suzhou) Pharmaceutical Co., Ltd.

Document name: Notification of Publication and of Entering the Substantive Examination Stage of the Application for Invention

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141029